These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11938026)

  • 21. HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis.
    Distante S; Berg JP; Lande K; Haug E; Bell H
    Gut; 2000 Oct; 47(4):575-9. PubMed ID: 10986220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes.
    Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G
    Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of H63D homozygosity in a Basque population with hemochromatosis.
    Castiella A; Zapata E; de Juan MD; Otazua P; Fernandez J; Zubiaurre L; Arriola JA;
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1295-8. PubMed ID: 20594259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of hemochromatosis susceptibility gene mutations in protecting against iron deficiency in celiac disease.
    Butterworth JR; Cooper BT; Rosenberg WM; Purkiss M; Jobson S; Hathaway M; Briggs D; Howell WM; Wood GM; Adams DH; Iqbal TH
    Gastroenterology; 2002 Aug; 123(2):444-9. PubMed ID: 12145797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation between HFE mutations and mild iron-overload expression.
    Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C
    Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
    Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
    Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women.
    Rossi E; Olynyk JK; Cullen DJ; Papadopoulos G; Bulsara M; Summerville L; Powell LW
    Clin Chem; 2000 Feb; 46(2):162-6. PubMed ID: 10657371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes.
    Sampson MJ; Williams T; Heyburn PJ; Greenwood RH; Temple RC; Wimperis JZ; Jennings BA; Willis GA
    J Lab Clin Med; 2000 Feb; 135(2):170-3. PubMed ID: 10695662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relevance of hemochromatosis-related HFE C282Y/H63D gene mutations in patients on chronic dialysis.
    Canavese C; Bergamo D; Barbieri S; Timbaldi M; Thea A; Martina G; Damiani D; Fenoglio R; Donati-Marella B; Priolo G
    Clin Nephrol; 2002 Dec; 58(6):438-44. PubMed ID: 12508966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.
    Bonkovsky HL; Jawaid Q; Tortorelli K; LeClair P; Cobb J; Lambrecht RW; Banner BF
    J Hepatol; 1999 Sep; 31(3):421-9. PubMed ID: 10488699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y.
    Wallace DF; Walker AP; Pietrangelo A; Clare M; Bomford AB; Dixon JL; Powell LW; Subramaniam VN; Dooley JS
    J Hepatol; 2002 Apr; 36(4):474-9. PubMed ID: 11943417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan.
    Shiono Y; Ikeda R; Hayashi H; Wakusawa S; Sanae F; Takikawa T; Imaizumi Y; Yano M; Yoshioka K; Kawanaka M; Yamada G
    Intern Med; 2001 Sep; 40(9):852-6. PubMed ID: 11579943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential HFE allele expression in hemochromatosis heterozygotes.
    Rosmorduc O; Poupon R; Nion I; Wendum D; Feder J; Béréziat G; Hermelin B
    Gastroenterology; 2000 Oct; 119(4):1075-86. PubMed ID: 11040194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
    Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
    Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatment.
    Infanti L; Leitner G; Moe MK; Pehlic V; Benkert P; Cattaneo M; Holbro A; Passweg J; Worel N; Buser A
    Blood Cells Mol Dis; 2022 Nov; 97():102689. PubMed ID: 35780678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study.
    Zaloumis SG; Allen KJ; Bertalli NA; Turkovic L; Delatycki MB; Nicoll AJ; McLaren CE; English DR; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Gurrin LC;
    J Gastroenterol Hepatol; 2015 Apr; 30(4):719-25. PubMed ID: 25311314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
    Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
    Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.
    Gochee PA; Powell LW; Cullen DJ; Du Sart D; Rossi E; Olynyk JK
    Gastroenterology; 2002 Mar; 122(3):646-51. PubMed ID: 11874997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.